Ensure Market Access

Broad and quality access depends on engaging all:

The Patient, Payer and Provider

 

Market success is not dependent upon the multi-year drug development and promised benefits of your drug. Market success is dependent upon Market Access. Navigating today’s shifting healthcare landscape is complicated. Never before has the healthcare industry witnessed such promising treatments entering the marketplace, yet facing so many challenges.

With our holistic approach we evaluate market share and improve pull-through efforts by looking deeply into key plans driving low regional share and performed analyses (e.g., spillover, rejections) to identify opportunities to increase share.

Powering Market Access with Data & Analytics

We bring an unrivaled understanding of the reimbursement and cost-and-coverage dynamics that matter to stakeholders, from health plan medical directors to specialty pharmacy. Our capabilities and expertise on pre-launch, launch, and mature products encompass access and reimbursement issues, advocate development, stakeholder education, promotional programs, and sales training communications. We are committed to delivering solutions that support all payer customer channels for our clients.

With ACTICS by EVERSANA, clients can power their market access success through:

  • The ability to predict and quantify gross-to-net for contracting market access, rebates, formulary position and optimize launch dynamics as well as determine opportunities and metrics for VBC
  • Predict, monitor, measure and optimize pull through, sales force, account management opportunities and utilization
  • Assess market entry and competitive contract dynamics and opportunities
  • Fold in payer and IDN influence into overall KOL mapping for complete view of access control

Value is achieved with Comprehensive Services, including:

  • Market Assessment & Insights

    Market Assessment & Insights

    The intelligence you need to validate or inform your strategy across the product life cycle.

    Learn More
  • Global Pricing Data & Software

    Global Pricing Data & Software

    Assess your pricing and launch strategies globally. Answer the complex questions impacting your revenue.

    Learn More
  • Market Access Strategy & Stakeholder Engagement

    Market Access Strategy & Stakeholder Engagement

    Breaking down the complexity of reimbursement and access. Engaging the Patient, Payer and Provider.

    Learn More
  • Global Channel & 3PL

    Global Channel & 3PL

    Distribution from Day 1 including special logistics for regenerative medicine.

    Learn More
  • Specialty & Direct-to-Patient Distribution

    Specialty & Direct-to-Patient Distribution

    Get therapies to patients quickly and effectively. We manage inventory, payer relationships, cash flow and wraparound patient service needs.

    Learn More
  • Affordability Programs

    Affordability Programs

    Help your patients secure treatments by offering options to manage cost.

    Learn More

Ask the Experts: How Does Real World Evidence Ensure Market Access?

With advancements in big data technologies and the sophistication of health information exchange, payers and providers are building analytic capabilities to identify real world unmet needs, along with areas of cost containment and efficiency. The development of digital medicines, apps, wearables, and biosensors that gather and store large amounts of health-related data has also accelerated. So, given the number of converging factors, how do we ensure that patients have access to the medicines they need, when, and where they need them?

READ

QUESTIONS? REACH OUT TO OUR EXPERTS

Contact Form

  • This field is for validation purposes and should be left unchanged.